公开(公告)号：CA2463491C

公开(公告)日：2011-07-26

申请号：CA2463491

申请日：2002-10-09

Applicant: SANDSTROM ROBERT E

Inventor： SANDSTROM ROBERT E

IPC: A61N2/04 ,  A61N1/40 ,  A61N2/00 ,  A61N5/10

Abstract: A method of treating a tumor, comprising creating an elevated concentration of free radicals in said tumor (22) and creating a magnetic field (20) that traverses said tumor (22) and that inhibits the recombination of said free radicals in said tumor. A magnetic field of 0.1 mTesla to 10 mTesla is generally used for this purpose.

公开(公告)号：GB2468403A

公开(公告)日：2010-09-08

申请号：GB201003537

申请日：2010-03-03

Applicant: SANDSTROM ROBERT E

Inventor： CRUM LAWRENCE A ,  SANDSTROM ROBERT E

IPC: G01N29/06 ,  A61B8/08 ,  G01N29/265

Abstract: A tissue specimen 13 imaging device 10 comprises a container 14 having an upwardly facing surface, adapted to receive a tissue specimen 13 and a liquid, and an ultrasound imaging assembly 20, adapted to automatically form a three dimensional image of the tissue specimen interior. The device includes a transducer head 18 with one or two arrays of transducers that is automatically moved relative to the specimen to form an image. The image or tissue specimen may be marked to indicate where to subsequently take tissue sections of the specimen.

公开(公告)号：GB2396302A

公开(公告)日：2004-06-23

申请号：GB0408373

申请日：2002-10-09

Applicant: SANDSTROM ROBERT E

Inventor： SANDSTROM ROBERT E

IPC: A61N1/40 ,  A61N2/00 ,  A61N5/10 ,  A61N2/04

Abstract: A method of treating a tumor, comprising creating an elevated concentration of free radicals in said tumor (22) and creating a magnetic field (20) that traverses said tumor (22) and that inhibits the recombination of said free radicals in said tumor. A magnetic field of 0.1 mTesla to 10 mTesla is generally used for this purpose.

公开(公告)号：GB2522583A

公开(公告)日：2015-07-29

申请号：GB201508757

申请日：2013-10-25

Applicant: SANDSTROM ROBERT E

Inventor： SANDSTROM ROBERT E

IPC: A61N2/00 ,  A61N2/02 ,  A61N2/06 ,  A61N5/10 ,  A61N7/00

Abstract: In the treatment of a tumor (126) with radiation therapy (122) is enhanced by a weak magnetic field (130), the field strength time sequence of exposure and shape and contour of the magnetic field are varied to achieve desired results. In one separate aspect, exposure to a magnetic field (130) is continued after exposure to a free radical-creating therapy is ceased or diminished, thereby increasing the lifetimes of free radicals that have already been created. In another preferred embodiment a magnetic field (13) is strategically placed to avoid extending the lives of free radicals in tissue through which a free radical-creating beam must pass, to reach a tumor. This application discloses quantitative parameters for field strength and exposure time to create concentrations and reactivity of free radicals, including long-lived free radicals and discloses the use of shaped, contoured, and designed electromagnetic fields. A treatment planning station (200) is also disclosed.

公开(公告)号：GB201003537D0

公开(公告)日：2010-04-21

申请号：GB201003537

申请日：2010-03-03

Applicant: SANDSTROM ROBERT E

Abstract: A tissue specimen imaging device, comprising: a container having an upwardly facing surface, adapted to receive a tissue specimen and a liquid, an ultrasound imaging assembly, adapted to automatically form a three dimensional image of the tissue specimen interior. In one preferred embodiment the device includes a transducer head that is automatically moved relative to the specimen.

公开(公告)号：GB0408373D0

公开(公告)日：2004-05-19

申请号：GB0408373

申请日：2002-10-09

Applicant: SANDSTROM ROBERT E

IPC: A61N1/40 ,  A61N2/00 ,  A61N5/10

公开(公告)号：AU2016308859A1

公开(公告)日：2018-02-15

申请号：AU2016308859

申请日：2016-08-18

Applicant: SANDSTROM ROBERT E

Inventor： SANDSTROM ROBERT E

IPC: A61K50/00 ,  A61K33/34 ,  A61K39/395 ,  A61P35/00

Abstract: A method of killing cells of a targeted cell type in a patient body that utilizes nanoparticles (10) having a first portion (12), which when exposed to a target portion (14) of a targeted cell type (16), binds to the target portion and a second portion (10A), joined to the first portion, and comprised of a low resistivity material. The nanoparticles are introduced into a contact area where they contact cells of the targeted cell type. Contemporaneously, the contact area is exposed to a varying magnetic field of insufficient strength to increase the temperature of any part of the patient body by more than ten degrees Celsius, but which creates a current (20) at the nanoparticles sufficient to disrupt function of the targeted cell type.

公开(公告)号：GB201508757D0

公开(公告)日：2015-07-01

申请号：GB201508757

申请日：2013-10-25

Applicant: SANDSTROM ROBERT E

公开(公告)号：AU2019200986A1

公开(公告)日：2019-09-05

申请号：AU2019200986

申请日：2019-02-13

Applicant: SANDSTROM ROBERT E

Inventor： SANDSTROM ROBERT E

IPC: A61N2/02 ,  A61B17/52

Abstract: A therapeutic magnetic field device, is described, the device comprising (a) a magnetic field generator; (b) a magnetic field sensor; (c) a data entry panel, permitting a user to input time periods and electromagnetic field strengths, for an electromagnetic field 5 production regime; and (d) a data processor including non-transitory computer readable memory, adapted to control said magnetic field generator to output a magnetic field in accordance with data received from said data entry panel. Also described is a method for enhancing the chemotherapeutic treatment of cancer tumors, comprising the steps of placing the patient into the therapeutic magnetic field device; administering a 10 chemotherapeutic cocktail to a patient, wherein said chemotherapeutic cocktail comprises a first chemotherapeutic agent, said first chemotherapeutic agent having a biological half-life, and an optimal field strength that is dictated by a specific quantum state of said first chemotherapeutic agent; during administration of the chemotherapeutic cocktail, exposing the patient to a magnetic field; and after 15 administration of said chemotherapeutic cocktail, continuing to expose the patient to said magnetic field for a duration up to five-times the biological half-life of said first chemotherapeutic agent. Figure 1 Place and position patient in the therapeutic 12 magnetic field device Begin administering chemotherapeutic agent 16 Turn on magnetic field 18 Stop administering chemotherapeutic agent 20 Turn off magnetic field 22

公开(公告)号：GB201803258D0

公开(公告)日：2018-04-11

申请号：GB201803258

申请日：2016-08-18

Applicant: SANDSTROM ROBERT E

Abstract: A method of killing cells of a targeted cell type in a patient body that utilizes nanoparticles having a first portion, which when exposed to a target portion of a targeted cell type, binds to the target portion and a second portion, joined to the first portion, and comprised of a low resistivity material. The nanoparticles are introduced into a contact area where they contact cells of the targeted cell type. Contemporaneously, the contact area is exposed to a varying magnetic field of insufficient strength to increase the temperature of any part of the patient body by more than ten degrees Celsius, but which creates a current at the nanoparticles sufficient to disrupt function of the targeted cell type.